Manik Amin

Also affiliated with University of Chicago

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.”.

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04851-z

N/A

0DataRank · unranked

1 citations

Dylan B. Ness, Kathryn Cunningham Hourdequin, Gregory H. Ripple, Manik Amin, Sierra Lord-Halvorson +8 more

A pragmatic, single-arm clinical trial of a dose modification algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy

Supportive Care in Cancer(2025)10.1007/s00520-025-09784-0

N/A

0DataRank · unranked

0 citations

Tor D. Tosteson, Kathryn Cunningham Hourdequin, Gregory H. Ripple, Alexander D. Fuld, Konstantin H. Dragnev +9 more